Senores Pharmaceuticals Ltd Corporate Actions

Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

 Copy Link

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

Senores Stock Dips from High, Remains Above IPO Price

 Copy Link

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.